RPS Support Alerts
The RPS Support team are developing and publishing regular Support Alerts to help support you in your day to day roles. These will cover a wide range of subjects ranging from legal and ethical issues to clinical matters and aim to be informative, supportive and user-friendly. Topics will be identified as part of horizon scanning by the RPS Support team but will also be produced in response to real queries and issues raised by members.
This section also includes information about drug and device recalls, patient safety notices, health professional letters and other important communications concerning patient safety, thus enabling you to ensure that you meet any necessary clinical governance requirements.
To receive these alerts via email please subscribe by visiting My Preferences.
You can choose to view older Support Alerts by using the filter options in the Support Alert Archive box below and selecting specific a month or year.
Support Alerts archive
Company led recall: Bactroban 2% nasal ointment 3g/Bactroban 2% cream 15g – Beecham .....more
Patient Safety Alert: Addressing antimicrobial resistance through implementation of an antimicrobial .....more
Medical Device Alert: Accu-Chek mobile meter and Accu-Chek mobile test cassette manufactured .....more
Class 4 Drug Alert (caution in use): Pregabalin 75mg capsules - incorrect strength printed .....more
Pharmacy Voice have produced their first Patient Safety Bulletin. The bulletin contains information .....more
Medical Device Alert: All Accu-Chek Insight insulin pumps manufactured by Roche Diagnostics .....more
Medical Device Alert: Automatically retracting safety syringes including insulin syringes .....more
Company led recall: Chirocaine 5mg/ml solution for injection/concentrate for solution for .....more
The Welsh government have issued two Welsh Health Circulars. The first regarding Meningococcal ACWY .....more
The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a drug safety update following .....more
Parenteral Naloxone can already be administered for the purpose of saving life in an emergency, where .....more
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 drug alert: medicines .....more
The Department of Health have issued a letter for frontline healthcare professionals on FGM, which .....more
Public health England have issued an alert advising of an increase in harm from synthetic cannabis .....more